Key facts
- This page summarizes Karen A. Licitra's Form 4 filing for SI-BONE, Inc. (SIBN).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 28 Jun 2021, 17:12.
Karen A. Licitra - 25 Jun 2021 Form 4 Insider Report for SI-BONE, Inc. (SIBN)
- Reporting relationship
- Director
- Issuer ticker
- SIBN
- Reported as of
- 25 Jun 2021
- Net transaction value
- -$622,533
- SEC form
- 4
- Accepted by SEC
- 28 Jun 2021, 17:12:26 UTC
- Next SEC filing
- 23 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael A. Pisetsky, Attorney-in-Fact for Karen A. Licitra
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Karen A. Licitra filed Form 4 for SI-BONE, Inc. (SIBN) on 28 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$622,533.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SIBN
transaction
Common Stock
Options Exercise
- Transaction value
- $44,483
- Shares
- +10,297
- Change %
- +117%
- Price
- $4.32*
- Shares after
- 19,094
- Date
- 25 Jun 2021
- Ownership
- Direct
SIBN
transaction
Common Stock
Options Exercise
- Transaction value
- $48,000
- Shares
- +11,111
- Change %
- +58%
- Price
- $4.32*
- Shares after
- 30,205
- Date
- 25 Jun 2021
- Ownership
- Direct
SIBN
transaction
Common Stock
Sale
- Transaction value
- $370,301
- Shares
- -11,111
- Change %
- -37%
- Price
- $33.33
- Shares after
- 19,094
- Date
- 25 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
SIBN
transaction
Common Stock
Sale
- Transaction value
- $344,715
- Shares
- -10,297
- Change %
- -54%
- Price
- $33.48
- Shares after
- 8,797
- Date
- 25 Jun 2021
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SIBN
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -11,111
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 25 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,111
- Exercise price
- $4.32
- Footnotes
- F3
SIBN
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -10,297
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 25 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,297
- Exercise price
- $4.32
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Karen A. Licitra is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $33.19 to $33.57, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnotes.
Footnote F2
The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $33.29 to $33.78, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnotes.
Footnote F3
The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.